Abstract:Introduction Serious mental illness (SMI) is defined as any mental, behavioral, or emotional disorder resulting in serious functional impairment limiting one or more major life activities. It is thought that around 1 in 25 adults in the United States struggle with SMI. Recent evidence suggests that many types of SMI such as schizophrenia and bipolar disorder may be associated with an elevated risk of dementia. It is unknown whether SMI itself may be a risk factor for dementia. There is evidence that in some cases schizophrenia, schizoaffective disorder, and bipolar disorder may share a common etiology and a recent study in the veteran population suggested that patients with schizophrenia or bipolar disorder are at elevated risk of developing dementia when compared to patients without these psychiatric diagnoses, again suggesting that there may be something about SMI that predisposes individuals to dementia. In this study, we examined the cognitive and demographic characteristics of 75 patients with SMI residing as inpatients in a long-term psychiatric institute over the last 10 years who were evaluated for dementia with neurocognitive assessments. Methods We obtained retrospective data from 76 patients with SMI who were evaluated for dementia in a long-term inpatient setting. Of these patients, 50 were diagnosed with dementia and 26 were not. We compared the results of the test of pre-morbid function (TOPF), Wechsler Abbreviated Scale Intelligence (WASI), the repeatable battery for the assessment of neuropsychiatric symptoms (RBANS), and the mini-mental status examination (MMSE) between patients with SMI diagnosed with dementia and those without a dementia diagnosis. We also examined whether specific psychiatric disorders were associated with a diagnosis of dementia and whether other medical factors were associated with dementia diagnosis. Additionally, we reviewed imaging findings from a subset of patients. Results SMI patients with dementia showed dramatically reduced scores on the WASI, RBANS, and MMSE compared to patients with SMI without dementia. There may be a relative sparing of the language domain. Patients with SMI and dementia were more likely to have a diagnosis of schizophrenia or schizoaffective disorder and more likely to be diagnosed with hypertension and hyperlipidemia. Conclusions Patients with SMI and dementia show dramatically different performance on multiple cognitive measures. Specific psychiatric diagnoses and comorbid medical conditions were associated with dementia in patients with SMI. These findings provide directions for future research to investigate the etiology of dementia in SMI.

Unraveling the role of the renin-angiotensin system in severe mental illnesses: An insight into psychopathology and cognitive deficits

Impact of the Renin–Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives

Severe mental illness: cardiovascular risk assessment and management

Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases

Neurovascular dysfunction in psychiatric disorders: Underlying mechanisms and therapeutic approaches

The Central Renin Angiotensin II System – a Genetic Pathway, Functional Decoding and Selective Target Engagement Characterization in Humans

Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis

Involvement of Renin-Angiotensin system (RAS) components in mild traumatic brain injury

O4‐01‐04: Beneficial Effects of Angiotensin II Receptor Blockers on Metabolic Disorder‐induced Cognitive Impairment

A Retrospective Examination of Patients with Serious Mental Illness and Dementia in a Long-Term Inpatient Psychiatric Institution

Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19

Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer’s disease, sarcopenia, cancer, and COVID-19

Angiotensin-(1-7) and Mas receptor in the brain

The role of the brain renin-angiotensin system in Parkinson ́s disease

An Investigation of the Sodium Nitroprusside Effects on Serum Lipids in an Animal Model of Schizophrenia by the Magnetic Resonance Study

Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?

What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review

The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?

Angiotensin-(1–7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage

Shared Metabolic and Immune-Inflammatory, Oxidative and Nitrosative Stress Pathways in the Metabolic Syndrome and Mood Disorders